Johannes-Gutenberg-University

Vaccine protects against six diseases in infants

Published in Pharma Law Weekly, August 17th, 2004

Scientists have developed a vaccine effective against diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus infection in infants.

"Safety, reactogenicity and immunogenicity of GSK Biologicals' hexavalent DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) was assessed when used for primary vaccination at 3, 4, and 5 months of age (n=2,163), compared to the separate administration of DTPa-IPV/Hib and HBV vaccines (n=720)," researchers in Germany report.

"A similar safety and reactogenicity profile was demonstrated for both vaccine regimens, as well as a good immune response for all antigen components," said Fred Zepp and colleagues at...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2004-08-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry